Muscular Dystrophy: Symptoms, Types, Causes, and Treatment – Metropolis Healthcare

Posted: Published on February 20th, 2024

This post was added by Dr Simmons

What is Muscular Dystrophy?

Muscular dystrophy comprises a group of conditions causing progressive muscle weakness and reduced flexibility.

The following are the common muscular dystrophy types noticed-;

Muscular dystrophy is considered uncommon, with an overall prevalence of approximately 16 to 25 per 100,000 individuals in the United States. Duchenne muscular dystrophy stands out as the most prevalent form during childhood, while myotonic dystrophy takes precedence as the most common type in adulthood.

Muscular dystrophy symptoms primarily entail progressive muscle weakness, with specific signs and manifestations varying based on the type and age of onset.

Duchenne Type Muscular Dystrophy and Becker Muscular Dystrophy:

Other Types

The following muscular dystrophy causes are commonly reported-;

The following are the complications of muscular dystrophy:

The following are ways in which muscular dystrophy diagnosis is done:

Doctors recommend the following muscular dystrophy treatments:

As muscular dystrophy is genetically determined, there are currently no preventive measures available. However, if you are concerned about the risk of passing on this genetic condition, especially before planning to conceive, consider seeking genetic counselling from your healthcare provider. Prenatal testing may be an option for early diagnosis during pregnancy in certain situations.

Living with muscular dystrophy means managing a group of genetic diseases causing progressive muscle weakness and mass loss. Your outlook depends on the specific type, ranging from a normal to a reduced lifespan. Muscular dystrophy symptoms worsen over time, affecting your mobility and daily activities. Therefore, you will need a personalised plan, including physical therapy, medications, and, if necessary, surgery. Regular monitoring and support from your healthcare team are vital for effectively managing the condition.

The life expectancy of individuals with Duchenne Muscular Dystrophy (DMD) typically succumb to the condition around the age of 25. In contrast, Becker Muscular Dystrophy generally has a higher life expectancy, often extending into the 30s or 40s. Oculopharyngeal muscular dystrophy typically does not impact life expectancy. On the other hand, Emery-Dreifuss Muscular Dystrophy, developing in childhood or early adulthood, often allows individuals to live at least until middle age.

If you are dealing with muscular dystrophy or taking care of someone with the condition, it's crucial to be a proactive advocate. Ensuring the best medical care and maximising access to therapy is essential for the best possible quality of life. Joining a support group with your family can also provide a valuable opportunity to connect with others who share similar experiences.

If you observe indications of muscle weakness, like heightened clumsiness and frequent falling in yourself or your child, it is advisable to consult a physician. The symptoms may differ based on the type of muscular dystrophy, but they typically progress over time.

Muscular dystrophy encompasses a group of genetic conditions causing progressive muscle weakness. Its impact varies by type, with muscular dystrophy symptoms worsening over time. While there is currently no cure, muscular dystrophy treatment options aim to extend mobility and support heart and lung muscle strength. Regular monitoring and a supportive healthcare team are crucial. Metropolis Healthcare stands out as a premier laboratory in the country, offering extensive tests. Renowned for its accuracy and timely results, it excels in various specialised tests, including Enzyme tests, Genetic testing, Muscle biopsy, Heart-monitoring tests, Lung-monitoring tests, and Electromyography.

Read more:
Muscular Dystrophy: Symptoms, Types, Causes, and Treatment - Metropolis Healthcare

Related Posts
This entry was posted in Muscular Dystrophy Treatment. Bookmark the permalink.

Comments are closed.